Table 2.
Clinicopathologic features of patients according to methyation status
MR, methylation-resistant; MP, methylation-prone colorectal cancer; CEA, carcinoembryonic antigen; WD, well-differentiated; MD, moderately differentiated; PD, poorly differentiated; MUC, mucinous; MSI-H, microsatellite instability high frequency; MSI-L, microsatellite instability low frequency; MSS, microsatellite stable.
